List of Drug Master Files (KDMF) for Minocycline Hydrochloride Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

Question

Minocycline Hydrochloride Manufacturers | Traders | Suppliers

score 59 · Accepted Answer

We have 2 companies offering Minocycline Hydrochloride

Get in contact with the supplier of your choice:

List of Drug Master Files (KDMF) for Minocycline Hydrochloride Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

Minocycline Hydrochloride

Minocycline Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers

16 USDMF

6 CEP/COS

3 JDMF

2 KDMF

12 NDC API

10 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

46 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

175 FDF Dossiers

137 FDA Orange Book

3 Europe

7 Canada

2 Australia

6 South Africa

20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL

CAPSULE;ORAL - EQ 100MG BASE

CAPSULE;ORAL - EQ 50MG BASE

CAPSULE;ORAL - EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER, EXTENDED RELEASE;DENTAL - EQ 1MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 115MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 65MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 80MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

5 SPI Pharma

2 Seqens

8 DKSH

2 Jai Radhe Sales

4 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

13 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

4 ACG Worldwide

5 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

27 BASF

1 Clariant

10 Corel Pharma Chem

6 DFE Pharma

2 Finar

10 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

35 Kerry

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

2 Novo Excipients

4 Pharmatrans-Sanaq

CAPSULE;ORAL - EQ 75MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons